The treatment, sotatercept, when compared to placebo showed statistically significant improvement in exercise capacity in patients with pulmonary arterial hypertension.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/g1vlNAi
0 Comments